Memory Enriched Epstein-Barr Virus {EBV} Specific T-Cells with Broader Target Antigen Repertoire for the Treatment of EBV plus Malignancies

被引：0
|
作者：
Sharma, Sandhya [1 ,2 ]
Mehta, Naren [1 ]
Parikh, Kathan [1 ]
El-Ghazali, Ayea [1 ]
Woods, Mae [1 ]
Sauer, Tim [1 ]
Zhang, Huimin [1 ]
Mehta, Birju [1 ]
Torrano, Vicky [1 ]
Grilley, Bambi [1 ]
Heslop, Helen [1 ,3 ,4 ]
Rooney, Cliona [1 ]
机构：
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[2] Baylor Coll Med, Grad Sch Biomed Sci, Houston, TX 77030 USA
[3] Houston Methodist, Houston, TX USA
[4] Texas Childrens Hosp, Houston, TX 77030 USA
来源：
MOLECULAR THERAPY | 2021年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
141
引用
收藏
页码：71 / 72
页数：2
相关论文
共 50 条
  • [31] Biclonal expansion of T cells infected with monoclonal Epstein-Barr virus (EBV) in a patient with chronic, active EBV infection
    Toyabe, S
    Harada, W
    Uchiyama, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 134 (01): : 92 - 97
  • [32] Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection
    Ohga, S
    Nomura, A
    Takada, H
    Ihara, K
    Kawakami, K
    Yanai, F
    Takahata, Y
    Tanaka, T
    Kasuga, N
    Hara, T
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (01): : 1 - 7
  • [33] Clinical Features and Treatment of Epstein-Barr virus (EBV) Ocular Infection
    Chen, Yueh-Ling
    Chen, Hung-Chi
    Hwang, Yih-Shiou
    Hsiao, Ching-Hsi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [34] Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1-Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
    Icheva, Vanya
    Kayser, Simone
    Wolff, Daniel
    Tuve, Sebastian
    Kyzirakos, Christina
    Bethge, Wolfgang
    Greil, Johann
    Albert, Michael H.
    Schwinger, Wolfgang
    Nathrath, Michaela
    Schumm, Michael
    Stevanovic, Stefan
    Handgretinger, Rupert
    Lang, Peter
    Feuchtinger, Tobias
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (01) : 39 - 48
  • [35] Epstein-Barr Virus-specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas
    Jones, Kimberley
    Vari, Frank
    Khanna, Rajiv
    Han, Erica
    Singh, Sanjleena
    Ritchie, David
    Gandhi, Maher K.
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 944 - 945
  • [36] Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma
    Sun, Q
    Burton, R
    Reddy, V
    Lucas, KG
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (03) : 799 - 808
  • [37] PARTIAL ELIMINATION OF EPSTEIN-BARR VIRUS (EBV) GENOMES IN VIRUS CARRYING CELLS
    TANAKA, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 123 - 123
  • [38] The Effects of Acute Malaria on Epstein-Barr Virus (EBV) Load and EBV-Specific T Cell Immunity in Gambian Children
    Njie, Ramou
    Bell, Andrew I.
    Jia, Hui
    Croom-Carter, Debbie
    Chaganti, Sridhar
    Hislop, Andrew D.
    Whittle, Hilton
    Rickinson, Alan B.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (01): : 31 - 38
  • [39] Epstein-Barr virus (EBV) nuclear antigen 1 colocalizes with cellular replication foci in the absence of EBV plasmids
    Ito, S
    Yanagi, K
    JOURNAL OF VIROLOGY, 2003, 77 (06) : 3824 - 3831
  • [40] IMMUNOPRECIPITATION OF EPSTEIN-BARR VIRUS (EBV)-SPECIFIC PROTEINS BY PRELYMPHOMATOUS AND NORMAL BABOON SERA CONTAINING ANTIBODIES REACTIVE WITH EBV EARLY ANTIGEN
    VOEVODIN, AF
    HIRSCH, I
    ACTA VIROLOGICA, 1985, 29 (03) : 242 - +
12345